(Organ, Tissue, Regeneration, Repair and Replacement)

 is an innovative company dedicated to the development of the Matrix Therapy in regenerative medicine with a new class of therapeutic agents, the RGTA^® (ReGeneraTing Agents).

The first two products developed from the RGTA^® technology are:

• CACIPLIQ20^®, cutaneous wound healing kit, prescribed for the treatment of chronic skin wounds including arteritic and venous ulcers, diabetic foot and pressure ulcers.

• CACICOL20^®, single-dose eye drops for corneal healing prescribed for chronic corneal lesions.